Results 41 - 50 of 122
Researchers
| Name | Track | Location | View profile |
|---|---|---|---|
| Biochemistry and Molecular Biology | Minnesota | ||
|
|
|||
| Biochemistry and Molecular Biology, Molecular Pharmacology and Experimental Therapeutics, Neuroscience, Virology and Gene Therapy | Minnesota | ||
IntroductionDr. Huang's laboratory integrates single-cell and spatial multi-omics, epigenomics, chemical biology, AI-based drug design and translational model systems to study brain tumors and neurodegenerative diseases. The lab combines patient-derived organoids and in vivo models to define disease mechanisms and actionable therapeutic targets and develop novel therapies. Trainees gain interdisciplinary expertise spanning cancer genomics, mechanistic biology, and chemical biology, with direct exposure to clinical questions and patient-relevant model systems. Recent work appears in Nature Genetics, Cell Stem Cell, Neuro-Oncology, and Science Signaling. |
|||
| Biomedical Engineering and Physiology, Clinical and Translational Science, Immunology, Molecular Pharmacology and Experimental Therapeutics, Regenerative Science, Virology and Gene Therapy | Arizona | ||
IntroductionGloria B. Kim, Ph.D., is an Assistant Professor of Biomedical Engineering and Immunology at Mayo Clinic in Arizona. Her laboratory develops next-generation immune cell therapies and immunoengineering technologies to treat cancer, inflammatory diseases, and organ injury. Research in the Kim Laboratory integrates cell therapy, synthetic biology, biomaterials, and translational engineering to advance clinically relevant therapies, including CAR-T cells, CAR-Tregs, and in vivo immune cell engineering. Dr. Kim is passionate about mentoring trainees and fostering an interdisciplinary research environment that bridges engineering, immunology, and medicine. |
|||
| Immunology | Arizona | ||
IntroductionDr. Ramos is a physician-scientist specializing in inflammatory bowel diseases who trained at Mayo Clinic, Boston Children’s Hospital and Harvard Medical School. Our research focuses on the mechanisms by which inflammatory signals alter intestinal stem cell fate and tissue remodeling, and how these processes contribute to chronic inflammatory diseases such as Crohn’s disease and ulcerative colitis. Using patient-derived organoids, immune co-cultures, gut-on-chip technologies, single-cell genomics, epigenomics, and prospective clinical biobanking, the laboratory seeks to define mechanisms of epithelial-immune communication and translate these discoveries into novel therapeutic strategies for immune-mediated diseases. |
|||
| Molecular Pharmacology and Experimental Therapeutics | Arizona | ||
IntroductionIn the Lomberk Lab, trainees explore how epigenetic and stress-response mechanisms allow cancer cells, particularly pancreatic cancer cells, to adapt, survive, and resist therapy. The research bridges chromatin biology and cancer-cell identity, genome stability and DNA damage response, and preclinical pharmacology and therapeutic development, integrating structural and computational approaches to accelerate the translation of mechanistic discoveries into targeted therapies. Mentorship in the lab emphasizes curiosity, rigor, resilience, creativity, and independence, with a focus on helping trainees ask meaningful questions, follow the evidence, and connect molecular discoveries to patient-centered impact. |
|||
| Molecular Pharmacology and Experimental Therapeutics | Arizona | ||
IntroductionIn the Lomberk Lab, trainees explore how epigenetic and stress-response mechanisms allow cancer cells, particularly pancreatic cancer cells, to adapt, survive, and resist therapy. The research bridges chromatin biology and cancer-cell identity, genome stability and DNA damage response, and preclinical pharmacology and therapeutic development, integrating structural and computational approaches to accelerate the translation of mechanistic discoveries into targeted therapies. Mentorship in the lab emphasizes curiosity, rigor, resilience, creativity, and independence, with a focus on helping trainees ask meaningful questions, follow the evidence, and connect molecular discoveries to patient-centered impact. |
|||
| Immunology | Minnesota | ||
IntroductionOur lab combines clinical insights with basic science to explore how T cells respond to cancer and to develop new immunotherapy strategies. Trainees in the lab gain experience in both translational and mechanistic research, with a particular focus on identifying immune-intrinsic factors that shape anti-tumor immunity and influence responses to therapies such as immune checkpoint inhibitors (ICIs). We emphasize collaborative, hypothesis-driven research and aim to equip trainees with the skills needed to connect laboratory discoveries to clinical impact. |
|||
| Immunology | Arizona | ||
IntroductionDr. Kita joined the faculty at Mayo Clinic Minnesota in 1994 and moved to Arizona in 2019. Dr. Kita’s laboratory is committed to understanding immunologic mechanisms of allergic diseases, such as asthma and food allergy, and type 2 immunity and developing novel strategies to prevent the disease and to treat patients safely and effectively. His multidisciplinary team, consisting of immunologists, cell and molecular biologists, clinicians and bioinformaticians, creates an environment for collaborative research and training for undergraduate and graduate students and postdoctoral fellows. He has mentored 11 Ph.D. students to completion and trained over 94 undergraduate and post-doctoral fellows. |
|||
| Immunology | Minnesota | ||
IntroductionMy research centers on metabolic regulation of adaptive immunity. We use genetic mouse models to study how cellular metabolism instruct B cell and T cell activation and differentiation. Using patient biopsies, we investigate the immunological basis of autoimmune diseases, including rheumatoid arthritis, lupus, lupus nephritis and autoimmune toxicities following cancer immunotherapy. |
|||
| Biochemistry and Molecular Biology, Biomedical Engineering and Physiology, Clinical and Translational Science, Molecular Pharmacology and Experimental Therapeutics, Neuroscience, Regenerative Science | Minnesota | ||
IntroductionDr. Isobel Scarisbrick leads Mayo Clinic’s Neural Regeneration Laboratory, a multidisciplinary team dedicated to restoring function after neurotrauma, demyelination, and aging. Our research integrates molecular and cellular neuroscience, stem cell biology, regenerative medicine, and neurorehabilitation to uncover mechanisms of neural repair and translate discoveries to new therapies. Graduate students thrive in a collaborative environment with training in advanced technologies, experimental design, scientific communication, and translational research. If you are driven to advance regenerative neuroscience, the Scarisbrick Lab offers an exceptional opportunity to contribute to discoveries shaping the future of neural repair and recovery. |
|||